- Home
- AAPG vs BGM Comparison
AAPG vs BGM Comparison
Compare AAPG & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- BGM
- Stock Information
- Founded
- AAPG 2009
- BGM 2019
- Country
- AAPG China
- BGM China
- Employees
- AAPG N/A
- BGM N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- AAPG Health Care
- BGM
- Exchange
- AAPG Nasdaq
- BGM NYSE
- Market Cap
- AAPG 3.2B
- BGM 2.6B
- IPO Year
- AAPG 2025
- BGM 2021
- Fundamental
- Price
- AAPG $38.24
- BGM $9.31
- Analyst Decision
- AAPG Buy
- BGM
- Analyst Count
- AAPG 1
- BGM 0
- Target Price
- AAPG N/A
- BGM N/A
- AVG Volume (30 Days)
- AAPG 12.4K
- BGM 88.0K
- Earning Date
- AAPG 08-06-2025
- BGM 08-13-2025
- Dividend Yield
- AAPG N/A
- BGM N/A
- EPS Growth
- AAPG N/A
- BGM N/A
- EPS
- AAPG N/A
- BGM N/A
- Revenue
- AAPG $134,352,180.00
- BGM $25,097,951.00
- Revenue This Year
- AAPG N/A
- BGM N/A
- Revenue Next Year
- AAPG $389.09
- BGM N/A
- P/E Ratio
- AAPG N/A
- BGM N/A
- Revenue Growth
- AAPG 341.77
- BGM N/A
- 52 Week Low
- AAPG $16.50
- BGM $5.26
- 52 Week High
- AAPG $43.58
- BGM $17.17
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- BGM 31.78
- Support Level
- AAPG N/A
- BGM $9.67
- Resistance Level
- AAPG N/A
- BGM $10.99
- Average True Range (ATR)
- AAPG 0.00
- BGM 1.01
- MACD
- AAPG 0.00
- BGM -0.30
- Stochastic Oscillator
- AAPG 0.00
- BGM 5.98
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.